Effect of Flex-a-New on Osteoarthritis of the Knee

This study is currently recruiting participants.

Verified by Rabin Medical Center, February 2006

Sponsored by:	Rabin Medical Center
Information provided by:	Rabin Medical Center
ClinicalTrials.gov Identifier:	NCT00294801

Purpose

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Condition	Intervention	Phase
Osteoarthritis	Drug: flex-a-new (food supplement)	Phase IV

MedlinePlus related topics: Dietary Supplements Osteoarthritis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:

KOOS

Secondary Outcome Measures:

VAS KSS

Estimated Enrollment:	80
Study Start Date:	January 2006
Estimated Study Completion Date:	December 2007

Detailed Description:

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

Eligibility

Ages Eligible for Study:	18 Years to 85 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

knee osteoarthritis grade 1 to 3 -

Exclusion Criteria:

ischemic heart disease with CHF -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00294801

Locations

Israel
Rabin Medical Center	Recruiting
Petah Tikwa, Israel, 49372
Contact: dror robinson, md 972-3-9372233 drorr@clalit.org.il
Principal Investigator: dror robinson, md

Sponsors and Collaborators

Rabin Medical Center

Investigators

Principal Investigator:

dror robinson

Rabin Medical Center

More Information

Study ID Numbers:	flex-a-new
Study First Received:	February 21, 2006
Last Updated:	February 21, 2006
ClinicalTrials.gov Identifier:	NCT00294801
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Rabin Medical Center:

knee osteoarthritis

Study placed in the following topic categories:

Osteoarthritis, Knee
Musculoskeletal Diseases
Osteoarthritis

Joint Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on January 16, 2009